Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $631.71 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $407.67 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $122.69 | 1 | $0 (2018) |
| The Medicines Company | $53.51 | 1 | $0 (2017) |
| Allergan Inc. | $24.68 | 2 | $0 (2018) |
| PFIZER INC. | $23.16 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $565.79 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($407.67) |
| 2017 | $65.92 | 2 | The Medicines Company ($53.51) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug) | Food and Beverage | In-kind items and services | $99.59 | General |
| Category: PAIN MEDICINE | ||||||
| 10/23/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $109.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $122.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/02/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $98.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/03/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/27/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2017 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $53.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 583 | 602 | $1.2M | $76,150 |
| 2022 | 6 | 562 | 624 | $584,594 | $55,516 |
| 2021 | 6 | 537 | 576 | $516,018 | $51,141 |
| 2020 | 5 | 610 | 650 | $658,612 | $63,888 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 400 | 417 | $879,201 | $57,197 | 6.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 121 | 123 | $167,713 | $11,161 | 6.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 40 | $94,136 | $6,826 | 7.3% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 22 | 22 | $17,074 | $965.78 | 5.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 238 | 275 | $418,930 | $40,240 | 9.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 30 | 31 | $54,843 | $5,844 | 10.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 53 | 57 | $59,154 | $5,489 | 9.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 42 | 46 | $31,470 | $2,545 | 8.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 151 | 164 | $19,024 | $1,044 | 5.5% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 48 | 51 | $1,173 | $353.07 | 30.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 209 | 223 | $338,068 | $33,714 | 10.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 42 | 46 | $80,684 | $8,866 | 11.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 54 | 58 | $59,508 | $5,740 | 9.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 25 | 25 | $17,075 | $1,407 | 8.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 153 | 167 | $19,372 | $1,032 | 5.3% |
| 71045 | X-ray of chest, 1 view | Facility | 2021 | 54 | 57 | $1,311 | $382.83 | 29.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 274 | 296 | $448,736 | $43,982 | 9.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 46 | 47 | $82,438 | $9,572 | 11.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 68 | 71 | $72,846 | $6,637 | 9.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 46 | 48 | $32,784 | $2,405 | 7.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 176 | 188 | $21,808 | $1,292 | 5.9% |
About Daniel Dorton
Daniel Dorton is a Emergency Medicine healthcare provider based in Lawton, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1013323815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Dorton has received a total of $631.71 in payments from pharmaceutical and medical device companies, with $565.79 received in 2018. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($631.71).
As a Medicare-enrolled provider, Dorton has provided services to 2,292 Medicare beneficiaries, totaling 2,452 services with total Medicare billing of $246,695. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Lawton, OK
- Active Since 07/01/2014
- Last Updated 07/01/2014
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1013323815
Products in Payments
- XIFAXAN (Drug) $198.96
- DIFICID (Drug) $122.69
- RELISTOR (Drug) $109.12
- LUCEMYRA (Drug) $99.59
- ORBACTIV (Drug) $53.51
- ELIQUIS (Drug) $23.16
- DALVANCE (Drug) $12.41
- AVYCAZ (Drug) $12.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Lawton
Dr. Jeffrey Golightly, M.d, M.D
Emergency Medicine — Payments: $2,236
Jessica Meador, D.o, D.O
Emergency Medicine — Payments: $830.67
Matthew Wood, D.o, D.O
Emergency Medicine — Payments: $529.56
Dr. William Murry, D.o, D.O
Emergency Medicine — Payments: $436.95
Jordan Price, Do, DO
Emergency Medicine — Payments: $428.66
Dr. Alexander Swan, Do, DO
Emergency Medicine — Payments: $368.13